List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 180 studies with search of: Open Studies | "Esophageal Neoplasms"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Capecitabine (Xeloda)
2 Recruiting A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Procedure: Esophagectomy
3 Not yet recruiting Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: CD40 Ligand Gene (AdcuCD40L)
4 Not yet recruiting Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: AdcuCD40L
5 Recruiting Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
Conditions: Esophageal Neoplasms;   Thoracic Surgery
Interventions: Other: Preoperative treatment of chemotherapy and radiation;   Other: Postoperative treatment of chemotherapy and radiation
6 Recruiting Genetic and Environmental Risk Factors Related to Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: questionnaire administration
7 Recruiting Identifying Genetic Markers for Esophageal Cancer and Stomach Cancer in Chinese Populations
Conditions: Esophageal Cancer;   Gastric Cancer
Interventions: Genetic: DNA analysis;   Genetic: genetic linkage analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: study of high risk factors
8 Recruiting Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: immunohistochemistry staining method;   Radiation: radiation therapy
9 Recruiting Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
Conditions: Esophageal Cancer;   Adenocarcinoma of the Esophagus;   Squamous Cell Carcinoma
Interventions: Drug: OncoGel (Paclitaxel gel);   Drug: cisplatin;   Drug: 5-FU;   Radiation: radiation therapy;   Procedure: esophageal resection
10 Recruiting Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Biological: cetuximab;   Drug: capecitabine;   Drug: cisplatin;   Radiation: radiation therapy
11 Recruiting Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer;   Gastric Cancer
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: microarray analysis;   Genetic: protein analysis;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Other: questionnaire administration
12 Recruiting Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: paclitaxel;   Radiation: radiation therapy
13 Recruiting Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Conditions: Colorectal Cancer;   Esophageal Cancer
Interventions: Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: endoscopic biopsy
14 Recruiting Radiation Therapy and Combination Chemotherapy as First-Line Therapy in Treating Patients With Esophageal Cancer That Cannot Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: cisplatin;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
15 Recruiting Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus
Condition: Esophageal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiation therapy
16 Recruiting Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Mediastinal or Chest Wall Neoplasms, or Lung Metastases From Cancers of Non-Thoracic Origin
Conditions: Esophageal Cancer;   Lung Cancer;   Malignant Mesothelioma;   Metastatic Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Procedure: bronchoscopy;   Procedure: endoscopic biopsy;   Procedure: needle biopsy
17 Recruiting Chemotherapy and Radiation Therapy in Treating Patients With Invasive Cancer of the Esophagus
Condition: Esophageal Cancer
Interventions: Drug: systemic chemotherapy;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis;   Procedure: computed tomography;   Procedure: endoscopic procedure;   Radiation: radiation therapy
18 Recruiting Vandetanib, Oxaliplatin, and Docetaxel in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Interventions: Drug: docetaxel;   Drug: oxaliplatin;   Drug: vandetanib;   Other: placebo
19 Recruiting Vandetanib, Oxaliplatin, and Docetaxel in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Interventions: Drug: docetaxel;   Drug: oxaliplatin;   Drug: vandetanib;   Other: placebo
20 Recruiting Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Condition: Esophageal Cancer
Interventions: Drug: cisplatin;   Drug: irinotecan hydrochloride;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services